Curis Inc balance sheet
At the end of fiscal 2025, Curis Inc had total assets of $20.0m, total liabilities of $14.5m and shareholders' equity of $5.5m. It held $5.1m in cash against $0 of debt: net cash of $5.1m.
Balance sheet
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 7 | 8 | 15 | 13 | 10 | 8 | 33 | 26 | 38 | 24 | 15 | 130 | 40 | 20 | 27 | 20 | 5 | 5 |
| Receivables | — | 0 | 0 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 0 | — |
| Total current assets | — | 41 | 39 | 57 | 60 | 52 | 86 | 48 | 64 | 28 | 25 | 173 | 122 | 92 | 61 | 26 | 7 | 7 |
| Goodwill | — | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Total assets | — | 51 | 48 | 70 | 81 | 63 | 95 | 58 | 74 | 37 | 35 | 204 | 162 | 109 | 77 | 41 | 20 | 19 |
| Accounts payable | — | 3 | 2 | 3 | 2 | 2 | 4 | 6 | 5 | 3 | 4 | 4 | 6 | 3 | 3 | 3 | 6 | 5 |
| Deferred revenue (current) | — | — | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — | — |
| Total current liabilities | — | 3 | 4 | 4 | 7 | 10 | 11 | 14 | 14 | 13 | 7 | 10 | 13 | 10 | 22 | 19 | 14 | 14 |
| Short-term debt | — | — | — | — | 3 | 6 | 5 | 5 | 6 | 7 | 0 | 1 | 0 | — | 9 | 8 | 0 | — |
| Long-term debt | — | — | — | 30 | 28 | 23 | 20 | 15 | 36 | 29 | 0 | 0 | — | — | — | — | — | — |
| Total debt | 0 | 0 | 0 | 30 | 31 | 28 | 24 | 20 | 42 | 36 | 0 | 1 | 0 | 0 | 9 | 8 | 0 | 0 |
| Total liabilities | — | 5 | 8 | 36 | 35 | 33 | 30 | 28 | 50 | 42 | 69 | 74 | 72 | 62 | 58 | 47 | 15 | 14 |
| Shareholders' equity | 33 | 46 | 40 | 34 | 45 | 30 | 65 | 29 | 24 | −4 | −34 | 131 | 91 | 47 | 20 | −6 | 5 | 5 |
| Net debt (negative = net cash) | −7 | −8 | −15 | 17 | 21 | 21 | −9 | −6 | 3 | 12 | −15 | −129 | −40 | −20 | −18 | −12 | −5 | −5 |
| Shares outstanding | — | — | — | — | — | — | — | — | — | — | — | — | — | 10m | — | — | 13m | 2m |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 3 | 3 | 2 | 3 | 3 | 0 | — | — |
| Total current assets | 27 | 26 | 25 | 14 | 14 | 7 | 17 | 7 |
| Goodwill | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Total assets | 42 | 41 | 39 | 29 | 28 | 20 | 30 | 19 |
| Accounts payable | 4 | 3 | 5 | 4 | 4 | 6 | 7 | 5 |
| Total current liabilities | 22 | 19 | 20 | 19 | 20 | 14 | 15 | 14 |
| Short-term debt | — | 8 | 7 | 7 | 7 | 0 | — | — |
| Total debt | — | 8 | 7 | 7 | 7 | 0 | — | — |
| Total liabilities | 51 | 47 | 46 | 43 | 42 | 15 | 17 | 14 |
| Shareholders' equity | −9 | −6 | −7 | −14 | −15 | 5 | 13 | 5 |
| Shares outstanding | 6m | 8m | 10m | 11m | 13m | — | 40m | 2m |
Compare with peers
- Camp4 Therapeutics Corp balance sheet
- Ensysce Biosciences, Inc. balance sheet
- Ocugen, Inc. balance sheet
- Entrada Therapeutics, Inc. balance sheet
- Bolt Biotherapeutics, Inc. balance sheet
Head to head: CAMP vs CRISCRIS vs ENSCCRIS vs OCGN
More: Biotechnology stocks compared, Health Care sector, rankings of US companies